AFT launches Phase III MRD-guided breast cancer treatment trial — News-Medical
AFT launches Phase III MRD-guided breast cancer treatment trial — News-Medical ua.news
Онкология
Рак молочной железы
411 материалов по теме, собраны автоматически из проверенных источников
Онкология
Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer - News-Medical
Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer News-Medical
Онкология
Most women know about breast cancer risk factors, but fewer act on them
According to a new survey, most U.S. women understood breast cancer risk factors, but only a minority were taking action to help lower their risk.
Онкология
Рак молочной железы стал самым распространенным онкозаболеванием в Павлодарской области Казахстана
Рак молочной железы стал самым распространенным онкозаболеванием в Павлодарской области Казахстана Правда.Ру
Онкология
Breast Cancer Treatment in 2026: Precision Is Expanding While Surgery and Radiation Become More Selective
Breast Cancer Treatment in 2026: Precision Is Expanding While Surgery and Radiation Become More Selective Oncodaily
Онкология
Scientists study breast milk as an early detection tool for breast cancer
A new study taking place in Manchester is investigating whether breast milk could help detect breast cancer earlier than a blood test or a scan. The research, led by scientists at The University of Manchester, aims to improve how doctors detect breast cancer that develops during or just after pregnancy. It is often…
Онкология
Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer
Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer 2 Minute Medicine
🎗️
Онкология
Researchers Reveal How Aggressive Breast Cancer May Spread to the Brain
Researchers Reveal How Aggressive Breast Cancer May Spread to the Brain SciTechDaily
🎗️
Онкология
Natera, Alliance Foundation Trials Launch Phase III Trial for MRD-Guided Treatment in Breast Cancer
Natera, Alliance Foundation Trials Launch Phase III Trial for MRD-Guided Treatment in Breast Cancer Genome Web
Онкология
Phase III Trial Tests Blood-Based MRD Monitoring to Spare Breast Cancer Patients CDK4/6 Inhibitor Toxicity
Phase III Trial Tests Blood-Based MRD Monitoring to Spare Breast Cancer Patients CDK4/6 Inhibitor Toxicity Bioengineer.org
Онкология
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer BioSpace
Онкология
Рак молочной железы занял 19% в структуре онкозаболеваемости в России
Рак молочной железы занял 19% в структуре онкозаболеваемости в России Medvestnik
🎗️
Онкология
Рак молочной железы составил 1/5 от всех онкозаболеваний в России
Рак молочной железы составил 1/5 от всех онкозаболеваний в России Readovka.news
Онкология
A trial will test whether a blood test can spare some breast cancer patients an added drug
A trial will test whether a blood test can spare some breast cancer patients an added drug Stock Titan
Онкология
СМИ: пятая часть онкопатологий среди россиян пришлась на рак молочной железы
СМИ: пятая часть онкопатологий среди россиян пришлась на рак молочной железы gazeta.press